FDA Drug recall D-1292-2019
Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020
- FDA Drug
- Class I
- terminated
- Published 2019-05-22
On 2019-05-22 the FDA classified a Class I recall of Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020 by D B P Distribution, citing marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1292-2019 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2019-04-23 |
| Published | 2019-05-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | D B P Distribution |
| Distribution | US |
Product
Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020
Reason
Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.
Identifiers
| code_info | Expiration 12/29/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1292-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.